Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BATS BZX Real-Time Price
As of 11:21am ET
 +0.49 / +18.08%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 2.25, with a high estimate of 6.00 and a low estimate of 2.00. The median estimate represents a -29.69% decrease from the last price of 3.20.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since February, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.88%
Growthannually 12.78%


Growthquarterly 60.64%
Growthannually 4.26%
Key to the earnings and sales forecast charts.